Edward Smolyansky Announces Campaign Updates, Files Revised Preliminary Consent Statement to Remove and Replace Lifeway Foods' Directors

Edward and Ludmila Smolyansky, holding 27% of Lifeway Foods (LWAY), are publicly criticizing the company's Q1 2025 performance and board governance, despite a reported 44% EPS increase driven by a one-time gain. They cite a nearly 55% decline in income from operations, a drop in operating margin to 3.4%, and slowing net sales growth, alongside concerns about rising selling expenses and insider stock sales, as evidence of mismanagement and misaligned priorities, and are seeking to reconstitute the board to explore strategic alternatives, including re-engaging with Danone.

Analysis

Lifeway Foods (LWAY) is currently embroiled in a significant shareholder activism campaign initiated by beneficial owners Edward and Ludmila Smolyansky, who collectively hold approximately 27% of the company's shares and have publicly expressed serious concerns regarding its Q1 2025 operational performance and corporate governance practices. The activists assert that a reported 44% year-over-year increase in GAAP earnings per share is misleading, being entirely attributable to a one-time $3.4 million gain from an investment sale, rather than any fundamental improvement in the core kefir business. They point to several troubling indicators: a nearly 55% year-over-year decrease in income from operations, a sharp contraction in operating margin to 3.4% from 7.9% a year prior, and a mere 3.3% year-over-year rise in net sales, which also saw a 1.8% sequential decline from Q4 2024. Additional operational red flags include a 50% revenue drop from the 2021 Glen Oaks acquisition, a 27% year-over-year spike in selling expenses unmatched by sales growth, a 180 basis point reduction in gross margin to 24.0%, and an increase in SG&A expenses to 20.2% of sales. Governance criticisms focus on recent insider stock sales by key executives, the Board's handling of a past Danone offer, substantial compensation packages for CEO/Chair Julie Smolyansky, and the governance risks associated with the combined CEO/Chair role. Consequently, the Smolyanskys are actively pursuing a consent solicitation to reconstitute the Board with independent nominees, aiming to enforce operational discipline and explore strategic alternatives, including potential re-engagement with Danone. The gravity of these allegations and the potential for a significant shift in company direction are underscored by a negative sentiment score of -0.8 and a high market impact score of 0.75 associated with this development.

Key Decisions for Investors

• Investors should closely monitor the progress and potential outcome of the Smolyanskys' consent solicitation, as a successful campaign could trigger substantial changes to Lifeway's board composition, strategic direction, and potentially unlock shareholder value through measures such as a re-engagement with Danone.
• Given the activists' detailed allegations of deteriorating operational performance, including a 55% decline in income from operations and contracting margins, investors should critically evaluate Lifeway's upcoming financial disclosures for tangible improvements in its core kefir business, independent of the activism outcome.
• The significant 27% stake held by the activist shareholders, coupled with their clear intent to force change, suggests a period of heightened uncertainty and potential stock price volatility for LWAY, warranting a careful assessment of risk exposure and the potential for strategic shifts.